You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HDGEC participant at Early-Manifest stage

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Huntington's Disease Trial in Worldwide (No Study Drug was Administered in this Study)

Completed
  • Huntington's Disease
  • No Study Drug was Administered in this Study
  • Englewood, Colorado
  • +14 more
Oct 26, 2021

Huntington Disease Trial in Amherst (Tominersen 60 mg, Placebo, Tominersen 100 mg)

Recruiting
  • Huntington Disease
  • Tominersen 60 mg
  • +2 more
  • Amherst, New York
    Dent Neurological
Jan 30, 2023

Huntington Disease Trial in Worldwide (Pridopidine, Placebo)

Active, not recruiting
  • Huntington Disease
  • Davis, California
  • +57 more
Dec 10, 2022

Osteonecrosis of the Femoral Head, Avascular Necrosis of the Femoral Head Trial in United States (Core Decompression, Core

Not yet recruiting
  • Osteonecrosis of the Femoral Head
  • Avascular Necrosis of the Femoral Head
  • Core Decompression
  • Core Decompression Procedure with Autologous Bone Marrow Aspirate Concentrate
  • Los Angeles, California
  • +11 more
Nov 6, 2023

Comparison Between [11C]UCB-J and [18F]SynVest-1 PET in HD.

Not yet recruiting
  • Huntington Disease
  • [11C]UCB-J
  • [18F]SynVest-1
  • Leuven, Belgium
    UZ Leuven
Nov 2, 2022

Parkinson Disease Trial (Gemfibrozil, Placebo)

Not yet recruiting
  • Parkinson Disease
  • (no location specified)
Jun 27, 2023

Huntington's Disease.

Recruiting
  • Huntington Disease
  • 7T MRI-scan
  • +3 more
  • Leiden, Zuid-Holland, Netherlands
    Leiden University Medical Centre
Sep 5, 2022

Parkinson Disease, Neurologic Disorder Trial in Ljubljana (Noninvasive transcutaneous auricular vagus nerve stimulation at

Recruiting
  • Parkinson Disease
  • Neurologic Disorder
  • Noninvasive transcutaneous auricular vagus nerve stimulation at 100Hz
  • +2 more
  • Ljubljana, Slovenia
    Neurology Department, UMC Ljubljana
Jul 31, 2023

NSCLC Trial (Dupilumab, Cemiplimab)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Dupilumab
  • Cemiplimab
  • (no location specified)
Oct 12, 2023

NSCLC Trial in Worldwide (Atezolizumab)

Recruiting
  • Non-small Cell Lung Cancer
  • Los Angeles, California
  • +43 more
Aug 5, 2022

Sentinel Lymph Node, Ovarian Carcinoma Trial in Istanbul (Sentinel lymph node biopsy (using sterile charcoal stain) in early

Recruiting
  • Sentinel Lymph Node
  • Ovarian Carcinoma
  • Sentinel lymph node biopsy (using sterile charcoal stain) in early ovarian cancer
  • Istanbul, Turkey
    Istanbul University
Jun 25, 2023

Nivolumab in Treatment of Early Stage Esophageal or

Not yet recruiting
  • Esophageal Carcinoma
  • Gastroesophageal Junction Carcinoma
    • Louisville, Kentucky
    • +2 more
    Mar 21, 2023

    Using Brain Diffusion MRI in X-linked Adrenoleukodystrophy

    Not yet recruiting
    • X-linked Adrenoleukodystrophy
    • brainQuant module of brainTale-care platform
    • (no location specified)
    Jun 12, 2023

    Mild Cognitive Impairment, Mild Dementia, Parkinson Disease Trial in United States (Placebo Oral Capsule, NYX-458)

    Active, not recruiting
    • Mild Cognitive Impairment
    • +3 more
    • Scottsdale, Arizona
    • +25 more
    Oct 26, 2022

    Amyotrophic Lateral Sclerosis Trial in Paris (Muscle biopsy)

    Active, not recruiting
    • Amyotrophic Lateral Sclerosis
    • Muscle biopsy
    • Paris, France
      Pitié-Salpêtrière Hospital
    Feb 17, 2022

    Bronchopulmonary Dysplasia, Child Development, Neonatal and Perinatal Conditions Trial in Québec (High-dose DHA, Control)

    Not yet recruiting
    • Bronchopulmonary Dysplasia
    • +2 more
    • High-dose DHA
    • Control
    • Québec, Quebec, Canada
      CHU de Québec-Université Laval
    Jun 20, 2023

    Early Breast Cancer Trial (Ribociclib, Letrozole, Ansastrozole)

    Not yet recruiting
    • Early Breast Cancer
    • (no location specified)
    Apr 12, 2023

    Alzheimer's Disease (AD) Trial in Italy, Portugal, United States (ABBV-916, Placebo)

    Recruiting
    • Alzheimer's Disease (AD)
    • Phoenix, Arizona
    • +87 more
    Dec 29, 2022

    Ductal Carcinoma in Situ Trial (Tamoxifen, Exemestane, Letrozole)

    Not yet recruiting
    • Ductal Carcinoma in Situ
    • (no location specified)
    Oct 13, 2023

    Polycystic Kidney, Autosomal Dominant Trial in Worldwide (Venglustat GZ402671, Placebo)

    Terminated
    Has Results
    • Polycystic Kidney, Autosomal Dominant
    • Birmingham, Alabama
    • +94 more
    Feb 1, 2023

    Early Manifest Huntington Disease Trial in Worldwide (Branaplam, Placebo)

    Active, not recruiting
    • Early Manifest Huntington Disease
    • Birmingham, Alabama
    • +21 more
    Sep 1, 2022

    Alzheimer, Mild Cognitive Impairment Trial (LEADing Dementia End-of-Life Planning Conversations)

    Not yet recruiting
    • Alzheimer Disease
    • Mild Cognitive Impairment
    • LEADing Dementia End-of-Life Planning Conversations
    • (no location specified)
    Jun 9, 2023

    Huntington Disease Trial in United States (intra-striatal rAAV5-miHTT, Imitation (sham) surgery)

    Recruiting
    • Huntington Disease
    • intra-striatal rAAV5-miHTT
    • Imitation (sham) surgery
    • Birmingham, Alabama
    • +11 more
    Dec 2, 2021

    Huntington Disease Trial in Paris (BV-101 Gene Therapy)

    Not yet recruiting
    • Huntington Disease
    • BV-101 Gene Therapy
    • Paris, Ile-de-France, France
      Institut du Cerveau (ICM), Hôpital La Pitié Salpêtrière APHP
    Sep 13, 2022

    Colorectal Cancer Trial

    Completed
    • Colorectal Cancer
      • (no location specified)
      Nov 8, 2023